Immunovant Inc. Common Stock vs Mitsubishi UFJ Financial Group Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.25B), while Mitsubishi UFJ Financial Group Inc. Common Stock trades at $22 (market cap $249.48B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 39.9× Immunovant Inc. Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays a 2.4% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Mitsubishi UFJ Financial Group Inc. Common Stock for 0 Days on average.
| IMVT | MUFG | |
|---|---|---|
Market Cap | $6.25B | $249.48B |
Volume | 1,755,411 | 4,008,160 |
Sector | Health | Financials |
52-Week High | $44.96 | $24.13 |
52-Week Low | $17.03 | $14.62 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $28.96T |
Dividend Yield | — | 2.4% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →